Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
True, OYMotion Pioneer Neuro AI Technology
True Corporation’s Research and Innovation Centre has teamed with neuro‑tech firm OYMotion to create a neuro‑AI platform that translates brain signals into commands for smart devices and prosthetics, aiming to accelerate rehabilitation. The system combines brain‑computer interface sensors, AI‑driven signal decoding, and True’s data network to deliver personalized, faster therapy for stroke, paralysis and mobility‑impairment patients. Pilot trials are underway in leading Thai hospitals, with plans to scale across the national health system and position Thailand as a regional neurotech hub.
Breakthrough Prize Showcases Baby Gene‑Editing Miracle
The 2026 Breakthrough Prize ceremony (“the Oscars for science”) celebrated the achievements of many remarkable scientists and their students and collaborators last weekend. Here’s the video of the show: https://t.co/eCHUnDqrYX. And here’s the segment in which Anne Hathaway and Alex...
MyBrainCo Partners Pharmacy Veteran to Gain Ground in New Sales Channel
Australian nutraceutical brand myBrainCo has partnered with StirlingFildes Plus, a 90‑year‑old pharmacy solutions provider, to accelerate entry into the pharmacy channel. The partnership gives myBrainCo access to StirlingFildes’ network of roughly 5,000 pharmacies, far exceeding the reach of traditional wholesalers like...
GSK Singapore Launches National Shingles Awareness Campaign “Wait For What?”
GlaxoSmithKline Singapore, together with Klick Health, has launched a national shingles awareness campaign titled “Wait For What?” that runs from March through June 2026. The multilingual effort features local celebrities Chen Shu Cheng, Richard Low and Zhu Hou Ren and spans TV, radio, digital, out‑of‑home and healthcare...
FDA Grants Breakthrough Therapy Designation to TERN-701 for Relapsed Ph+ CML
The FDA has awarded breakthrough therapy designation to TERN-701, Terns Pharmaceuticals’ oral BCR::ABL1 inhibitor, for adults with Philadelphia chromosome‑positive chronic myeloid leukemia who have failed at least two prior tyrosine kinase inhibitors. The decision follows phase 1/2 CARDINAL data showing...
MHRA Develops Adaptive AI Framework to Accelerate NHS Clinical Deployments
Britain's Medicines and Healthcare products Regulatory Agency (MHRA) is drafting a new regulatory framework for adaptive artificial‑intelligence tools that evolve with real‑world data. The guidance, focused on lifecycle oversight, seeks to streamline NHS adoption while ensuring continuous safety, performance and...
Noninvasive Skull Sensor Prevents Brain Injuries in Critically Ill ICU Patients
A Brazilian startup, brain4care, has validated a non‑invasive skull sensor that monitors intracranial compliance in real time. In a five‑year study of critically ill neuro‑ICU patients, adding the sensor to standard guideline‑based care cut mortality from 37.3% to 5.9% and...
UnitedHealthcare CEO Unveils $20‑Million CRC Initiative to Boost Customer Satisfaction
UnitedHealthcare chief executive Drew Anthony Smith announced a consumer‑incident resolution program that has already served 150,000 members, raised satisfaction scores to 8.8 out of 10 and generated $20‑25 million in cost savings. The rollout, built on AI and a 330‑person team,...
10x Genomics Unveils A
I've been watching spatial biology for years. What @10xGenomics just announced changes the game. Serge Saxonov, CEO and Co-founder, 10x Genomics told Synbiobeta, "Biology is inherently complex, and as much progress as we have made, we still understand only a...
Merck Beats EPS Forecast but Revenue Misses, Shares Slide 3.7% Pre‑Market
Merck & Co. reported Q2 2025 earnings that topped expectations on earnings per share, delivering $2.13 versus the $2.03 consensus. Revenue, however, slipped to $15.8 billion, missing the $15.87 billion outlook and prompting a 3.67% drop in the stock during pre‑market trading....
Strong Policies Required As Sugar Fuels Oral Health Crisis
The New Zealand Dental Association (NZDA) is urging the government to adopt stronger sugar‑reduction policies, warning that the current food environment fuels preventable oral disease, obesity and diabetes. It cites the WHO’s finding that 116 countries now tax sugary drinks...
CEO of For-Profit MA Plan Tells CMS “Pay Us Less”
Devoted Health CEO Ed Park told CMS at the Medicarians conference that the for‑profit Medicare Advantage (MA) plan would welcome lower government payments. He cited MedPAC’s March report showing MA enrollees cost the federal government $76 billion more than traditional Medicare....
Traditional MDs Now Seeking Peptide Knowledge for Joint Health
So many of my “conventional” (not in the health and wellness space or even online much) MD friends are asking about peptides to 1) get educated (patients are asking them about peptides) 2) they want to know if BPC can help their...
What If Endometriosis Is Not Just Hormonal? Scientists Are Looking at Bacteria
Endometriosis, long explained by retrograde menstruation, is now being re‑examined through a bacterial lens. A 2023 iScience review highlights that 64% of patients harbor Fusobacterium in the endometrium, suggesting microbes may trigger inflammation via LPS‑TLR4 signaling and facilitate lesion formation....
Asgard Therapeutics to Unveil AT‑108 Gene Therapy Data at ASGCT 2026
Asgard Therapeutics announced that it will present advanced preclinical data on AT‑108, its first‑in‑class off‑the‑shelf gene‑based cancer immunotherapy, at the ASGCT Annual Meeting in Boston (May 11‑15, 2026). The study shows systemic anti‑tumor immunity, an abscopal effect, and identifies dosing...
How Big Is Organon’s Biosimilar Push for Sun Pharma?
Sun Pharma’s $11.75 billion acquisition of Organon propels the Indian drugmaker into the global biosimilars market, placing it among the top ten players. Organon’s biosimilar portfolio generated $691 million in 2025, about 11 % of its total revenue, with 45 % of that coming...
Bacteria-Resistant Coating on Catheters Reduces Infection and Need for Antibiotics
A clinical trial of Camstent's bacteria‑resistant polymer‑coated catheter showed a one‑third drop in catheter‑associated urinary tract infections (CAUTIs) and more than a 50 % reduction in antibiotic use versus standard catheters. Long‑term patients using the coated device reported zero symptomatic CAUTIs...
Nautilus Biotechnology Inc (NAUT) Q1 2026 Earnings Call Transcript
Nautilus Biotechnology reported a 23% drop in Q1 operating expenses to $15.4 million and ended the quarter with $156.1 million in cash, extending its runway into 2027. Management guided to modest $0.5 million revenue in 2026, primarily from grant‑funded early access customers, while...
AxoGen Inc (AXGN) Q1 2026 Earnings Call Transcript
Axogen reported Q2 2025 revenue of $56.7 million, an 18.3% year‑over‑year increase, and posted a modest net profit of $0.6 million, turning quarterly profitability. Gross margin rose to 74.2% and operating expenses fell as a share of revenue, highlighting operating leverage. The...
Zimmer Biomet Holdings, Inc (ZBH) Q1 2026 Earnings Call Transcript
Zimmer Biomet reported Q1 2026 net sales of $2.087 billion, a 9.3% increase on a reported basis and 2.9% organic constant‑currency growth. Adjusted earnings per share rose 15% to $2.09, helped by a $0.20 tariff benefit, while adjusted gross margin reached...
AbbVie (ABBV) Maintains Dividend Strength as Core Drugs Drive Cash Flow
AbbVie remains a strong dividend payer as its newer immunology drugs, Skyrizi and Rinvoq, now generate more revenue than Humira ever did. In 2025 the pair delivered $25.9 billion in sales, outpacing Humira’s 2022 peak of $21.2 billion. The company raised its...
How Virtual Reality Therapy Could Change the Way Mental Disorders Are Treated
Virtual reality (VR) is emerging as a powerful adjunct to cognitive‑behavioral therapy, allowing clinicians to immerse patients in realistic anxiety‑provoking scenarios such as public speaking or flying. A recent literature review in Psychology Research and Behavior Management confirms that VR‑enhanced...
CDER Proposes to Withdraw Approval of TAVNEOS
The FDA’s Center for Drug Evaluation and Research has proposed withdrawing approval of TAVNEOS (avacopan) after uncovering data manipulation in the pivotal trial and a lack of demonstrated efficacy for severe ANCA‑associated vasculitis. The agency also flagged new safety signals,...
How a Mental Health Strategy Helps Young Adults Navigate Cancer Diagnosis
Rutgers University researchers evaluated Bright IDEAS, a CBT‑based problem‑solving program, in a randomized trial of 344 young adults (18‑39) newly diagnosed with cancer. Participants who completed six video sessions showed significant reductions in depression and anxiety and reported higher health‑related...
Lithium Interaction Poses Major Seizure Risk with Psilocybin
Most physicians were never taught psilocybin in medical school. Their patients in three states can now legally access it. Oregon's program has been operating since summer 2023. Colorado's healing centers came online in 2025. New Mexico passed its Medical Psilocybin...
Autologous iPSC Dopamine Cells Boost Parkinson’s Function without Immunosuppression
I’ve been following @jeannefrances's work for years, and what @AspenNeuro just reported out of Copenhagen is the kind of result that changes a field. Twelve months after receiving their own reprogrammed dopamine neurons, eight Parkinson's patients are showing real, measurable...
When Joe Rogan Is in Charge of Health Care
President Donald Trump signed an executive order that accelerates research funding and fast‑track FDA review for psychedelic therapies after podcaster Joe Rogan texted the president about their potential. The order directs the Department of Health and Human Services to boost...
ACA Marketplace Coverage Changes Reduce Hospital Revenue, Shift Payer Mix
Changes to ACA marketplace coverage in 2026 trimmed HCA Healthcare's adjusted EBITDA by $150 million in Q1, reflecting a 15% YoY drop in marketplace admissions and a rise in uninsured patients. The shift also slowed Medicaid conversions, as patients hesitate to...
Opportunistic AI Detects Colorectal Cancer Using Routine, Noncontrast CT
Researchers at Guangdong Provincial People’s Hospital unveiled COCA, an AI tool that detects colorectal cancer on routine non‑contrast abdominal and pelvic CT scans. In retrospective tests on more than 2,000 scans, COCA delivered an AUC between 0.967 and 0.996, boosting...
China Races to Build Record Biobank to Rival US Drugs Research
China is constructing a national biobank that will house blood and DNA samples from 33,000 children, targeting brain‑disease research. The initiative, led by the Chinese Institute for Brain Research, seeks to create a data‑rich platform that rivals the United States’...
Monday April 27, 2026
Policy and market forces converged this week as CMS and the FDA launched the RAPID coverage pathway, slashing Medicare approval timelines for breakthrough devices from over a year to as little as two months for roughly 40 qualifying products. Meanwhile,...
The BioPharm Brief: FDA Advances Autoimmune Pipeline with New Delivery Options and Priority Review
The FDA cleared a subcutaneous autoinjector for anifrolumab, allowing at‑home treatment of moderate‑to‑severe systemic lupus erythematosus. It also granted Priority Review to nipocalimab for warm autoimmune hemolytic anemia, a rare blood disorder, accelerating its path to market. AbbVie submitted a...
Great Work Deserves to Be Seen: 2026 Innovator Awards Now Open
The Healthcare Innovation Innovator Awards Program has opened nominations for its 2026 cycle, inviting teams from hospitals, health systems, payers, and other providers to showcase technology‑driven improvements. The contest emphasizes team‑based recognition, allowing participants to submit concise stories that the...
WARNING: UK Could Face Repeat Lockdowns Using the Same Pandemic Playbook
A former World Health Organization scientist, David Bell, warned that the draft WHO pandemic treaty could push the United Kingdom back into Covid‑era lockdowns, mask mandates and mass vaccination campaigns. The treaty, slated for final negotiations in Geneva, expands surveillance,...
Study Suggests Fibroid Rates in Latina Women May Be Lower than Previously Thought
A new Michigan Medicine study, the largest U.S. ultrasound‑confirmed investigation of uterine fibroids in Latina women, found an overall prevalence of 11.8%, notably lower than earlier estimates that reached 37%. The research, part of the ELLAS project and employing community‑based...
Timely by DrFirst Aims to Lower Barriers to Specialty Meds
Timely by DrFirst unveiled a provider‑focused solution that embeds actionable insights directly into e‑prescribing workflows. The tool boosts prior‑authorization (PA) completion to 60% for specialty drugs and cuts pharmacy change requests by 56%, while patient‑facing text messages achieve an 88%...
Conservative Physicians Accuse Medical Boards of Censorship
Two conservative physicians and a medical group asked the Fifth Circuit to revive claims that the American Board of Internal Medicine (ABIM) and the American Board of Obstetrics and Gynecology (ABOG) are threatening to strip board certifications for dissenting medical...
HIIT Boosts Brain Health in Heart Disease Patients
The Utility of High Intensity Interval Training to Improve Cognitive Aging in Heart Disease Patients “the physiology related to cerebral blood flow regulation and cognitive decline in adults with cardiovascular disease and heart failure, and how HIIT may provide a more...
Georgian Mall Family Dental: Building Smiles and Trust
Georgian Mall Family Dental, founded in 2013 in Barrie, Ontario, built its brand around a patient‑first philosophy rather than rapid expansion. By locating inside a busy mall and creating a calm, hotel‑like environment, the clinic earned strong word‑of‑mouth referrals and...
April 30, 2026: Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement - 04/30/2026
The FDA’s Oncologic Drugs Advisory Committee will meet on April 30, 2026 to evaluate two AstraZeneca submissions: NDA 220359 for camizestrant tablets combined with CDK4/6 inhibitors in ESR1‑mutated hormone‑receptor‑positive breast cancer, and sNDA 218197/S‑004 for Truqap (capivasertib) plus abiraterone in PTEN‑deficient metastatic hormone‑sensitive prostate...
Insurers Hide Denials, Charge Appeals—Demand Transparency Now
Want to know how ridiculous and awful Ins company and their PBM denials are? The insurance company that denies the claim, that is if it’s them and not a subcontractor like medica , also picked the network and doctors. So they...
Cellular Rejuvenation Could Shift Medicine to Youthful Resilience
Cellular rejuvenation may redefine medicine—not by treating disease, but by restoring youthful resilience at the cellular level. But science, safety, and hype are colliding. Worth the read (gift link) : 👇 https://t.co/7JGNdhFsFP via @NYTimes
The Coming War over the NDIS
Australian Health Minister Mark Butler announced a package of reforms to the National Disability Insurance Scheme (NDIS) aimed at capping program spending at roughly $55 billion AUD (≈$36 billion USD) by year‑end. The changes are projected to save about $22 billion AUD (≈$14.5 billion...
Profit‑Driven Healthcare Drains Billions, Harms Millions
The pursuit of health care under a profit driven predatory healthcare system is no great capitalist opportunity. It’s a brutal extraction of $billions daily from the U.S. economy and from the hard earned working lives of hundreds of millions. United...
‘It’s in Our DNA’: Nursing Home Giant PACS CEO on Compliance Transformation After Investigation, Growth, $100M Tech Investments
After a 2024 billing investigation, PACS Group (NYSE:PACS) revamped its compliance framework and poured roughly $100 million into technology, standardizing EMRs and real‑time dashboards across its 323 facilities. CEO Jason Murray says the changes have woven compliance into the company’s DNA,...
WVU Medicine Children’s Hospital Launches Breast Milk Donation Site
WVU Medicine Golisano Children’s Hospital in Morgantown has partnered with the Mid-Atlantic Mothers’ Milk Bank to operate a donor breast‑milk depot. The site allows screened donors to drop off milk, which is stored in the Little Mountaineer Pharmacy before being...
Viewpoint: Is AI Actually Improving Care Outcomes?
A recent correspondence in Nature Medicine argues that healthcare AI’s clinical benefits remain largely unproven. While many studies showcase algorithmic accuracy on retrospective data, they rarely assess real‑world patient outcomes. The authors, Jenna Wiens and Anna Goldenberg, call for randomized trials, prospective...
Building End-to-End, Intelligent Patient Flow at Scale
Health systems are turning to an integrated, AI‑driven operating model to streamline patient flow from admission to discharge. By unifying capacity management, admission planning, care progression, staff scheduling and discharge coordination, hospitals can anticipate bottlenecks and act proactively. Early adopters...
Beth Israel Lahey Health Names Network President
Boston‑based Beth Israel Lahey Health announced Sue Chapman Moss as president of its Performance Network. In the role, Moss will steer the clinically integrated network of physicians, clinicians and hospitals. She joins from Bayada Home Health Care, where she oversaw payer...
Intellia’s Data Reveal Tees Up FDA Filing for CRISPR-Based In Vivo Gene-Editing Med
Intellia Therapeutics filed a rolling FDA submission for lonvo‑z, its CRISPR‑based in‑vivo gene‑editing therapy for hereditary angioedema (HAE). In a placebo‑controlled Phase 3 trial of 80 patients, a single infusion cut swelling attacks by 87% versus placebo and left 62% of...